Clinical Trial Update: Mucomyst for Hepatitis C [NA]

View source ↗

Summary

A clinical trial evaluating Mucomyst (acetylcysteine) for hepatitis C has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Mucomyst (N-acetylcysteine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Hepatitis C | NA | Status: SUSPENDED